InsiderClue
Insiders · Profile

Gallagher Cam

Director at Opus Genetics · President, Interim CFO at Zentalis Pharmaceuticals. Filing since 19 Nov 2020. CIK 0001557832

IRD Opus Genetics, Inc. Director · 3 trades ZNTL Zentalis Pharmaceuticals, Inc. President, Interim CFO · 48 trades
Company
Date
Role
Action
Shares
Amount
Of holding
IRD Opus Genetics, Inc.
29 Dec 2025
Director
Bought
83,000
$163.42K
opened
IRD Opus Genetics, Inc.
29 Dec 2025
Director
Bought
81,000
$160.27K
4.5%
ZNTL Zentalis Pharmaceuticals, Inc.
31 May 2024
President, Interim CFO
Sold at will
9,597
$114.97K
1.5%
ZNTL Zentalis Pharmaceuticals, Inc.
12 Feb 2024
President
Sold at will
1,173
$13.42K
0.2%
ZNTL Zentalis Pharmaceuticals, Inc.
2 Feb 2024
President
Sold at will
11,552
$133.31K
1.8%
ZNTL Zentalis Pharmaceuticals, Inc.
31 May 2023
President
Sold on a plan
27,768
$729.51K
5.7%
ZNTL Zentalis Pharmaceuticals, Inc.
14 Feb 2023
President
Sold, plan not stated
8,501
$169.71K
1.7%
ZNTL Zentalis Pharmaceuticals, Inc.
13 Feb 2023
President
Sold, plan not stated
3,332
$68.05K
0.7%
ZNTL Zentalis Pharmaceuticals, Inc.
6 Feb 2023
President
Sold, plan not stated
10,000
$222.68K
1.9%
ZNTL Zentalis Pharmaceuticals, Inc.
17 Jan 2023
President
Sold, plan not stated
10,000
$241.51K
2.8%
ZNTL Zentalis Pharmaceuticals, Inc.
5 Jan 2023
President
Sold, plan not stated
10,000
$210.23K
2.7%
ZNTL Zentalis Pharmaceuticals, Inc.
15 Nov 2022
President
Sold, plan not stated
12,500
$284.68K
3.3%
ZNTL Zentalis Pharmaceuticals, Inc.
8 Nov 2022
President
Sold, plan not stated
12,374
$291.54K
3.1%
ZNTL Zentalis Pharmaceuticals, Inc.
7 Nov 2022
President
Sold, plan not stated
12,500
$295.86K
3.1%
ZNTL Zentalis Pharmaceuticals, Inc.
17 Oct 2022
President
Sold, plan not stated
12,500
$293.88K
3.0%
ZNTL Zentalis Pharmaceuticals, Inc.
6 Oct 2022
President
Sold, plan not stated
10,000
$226.18K
2.3%
ZNTL Zentalis Pharmaceuticals, Inc.
5 Oct 2022
President
Sold, plan not stated
12,500
$279.01K
2.8%
ZNTL Zentalis Pharmaceuticals, Inc.
16 Sep 2022
President
Sold, plan not stated
10,000
$244.50K
2.2%
ZNTL Zentalis Pharmaceuticals, Inc.
15 Sep 2022
President
Sold, plan not stated
12,500
$315.76K
2.7%
ZNTL Zentalis Pharmaceuticals, Inc.
5 Apr 2022
Director
Sold, plan not stated
10,000
$504.77K
2.7%
ZNTL Zentalis Pharmaceuticals, Inc.
15 Mar 2022
Director
Sold, plan not stated
10,000
$419.24K
2.7%
ZNTL Zentalis Pharmaceuticals, Inc.
7 Mar 2022
Director
Sold, plan not stated
10,000
$449.39K
2.6%
ZNTL Zentalis Pharmaceuticals, Inc.
15 Feb 2022
Director
Sold, plan not stated
10,000
$519.29K
2.5%
ZNTL Zentalis Pharmaceuticals, Inc.
14 Feb 2022
Director
Sold, plan not stated
7,188
$360.77K
1.8%
ZNTL Zentalis Pharmaceuticals, Inc.
7 Feb 2022
Director
Sold, plan not stated
10,000
$534.47K
2.5%
ZNTL Zentalis Pharmaceuticals, Inc.
18 Jan 2022
Director
Sold, plan not stated
10,000
$626.38K
2.5%
ZNTL Zentalis Pharmaceuticals, Inc.
5 Jan 2022
Director
Sold, plan not stated
10,000
$754.86K
2.4%
ZNTL Zentalis Pharmaceuticals, Inc.
15 Dec 2021
Director
Sold, plan not stated
10,000
$740.34K
2.3%
ZNTL Zentalis Pharmaceuticals, Inc.
6 Dec 2021
Director
Sold, plan not stated
10,000
$713.30K
2.3%
ZNTL Zentalis Pharmaceuticals, Inc.
15 Nov 2021
Director
Sold, plan not stated
10,000
$753.62K
2.2%
ZNTL Zentalis Pharmaceuticals, Inc.
5 Nov 2021
Director
Sold, plan not stated
10,000
$829.49K
2.2%
ZNTL Zentalis Pharmaceuticals, Inc.
1 Oct 2021
Director
Sold, plan not stated
10,000
$661.49K
2.1%
ZNTL Zentalis Pharmaceuticals, Inc.
1 Sep 2021
Director
Sold, plan not stated
10,000
$675.23K
2.1%
ZNTL Zentalis Pharmaceuticals, Inc.
2 Aug 2021
Director
Sold, plan not stated
10,000
$510.20K
2.1%
ZNTL Zentalis Pharmaceuticals, Inc.
7 Jul 2021
Director
Sold, plan not stated
2,572
$121.22K
0.5%
ZNTL Zentalis Pharmaceuticals, Inc.
6 Jul 2021
Director
Sold, plan not stated
15,798
$740.64K
3.1%
ZNTL Zentalis Pharmaceuticals, Inc.
2 Jul 2021
Director
Sold, plan not stated
10,000
$495.83K
1.9%
ZNTL Zentalis Pharmaceuticals, Inc.
1 Jun 2021
Director
Sold, plan not stated
10,000
$540.55K
1.9%
ZNTL Zentalis Pharmaceuticals, Inc.
3 May 2021
Director
Sold, plan not stated
10,000
$592.50K
1.9%
ZNTL Zentalis Pharmaceuticals, Inc.
6 Apr 2021
Director
Sold, plan not stated
165
$7.14K
0.0%
ZNTL Zentalis Pharmaceuticals, Inc.
5 Apr 2021
Director
Sold, plan not stated
28,204
$1.22M
5.0%
ZNTL Zentalis Pharmaceuticals, Inc.
1 Mar 2021
Director
Sold, plan not stated
10,000
$416.86K
1.7%
ZNTL Zentalis Pharmaceuticals, Inc.
1 Feb 2021
Director
Sold, plan not stated
10,000
$374.87K
1.8%
ZNTL Zentalis Pharmaceuticals, Inc.
4 Jan 2021
Director
Sold, plan not stated
10,000
$519.32K
1.7%
ZNTL Zentalis Pharmaceuticals, Inc.
24 Dec 2020
Director
Sold, plan not stated
18,473
$0.00
100%
ZNTL Zentalis Pharmaceuticals, Inc.
8 Dec 2020
Director
Sold, plan not stated
22,573
$1.28M
3.7%
ZNTL Zentalis Pharmaceuticals, Inc.
7 Dec 2020
Director
Sold, plan not stated
6,692
$358.17K
1.1%
ZNTL Zentalis Pharmaceuticals, Inc.
4 Dec 2020
Director
Sold, plan not stated
7,474
$381.05K
1.2%
ZNTL Zentalis Pharmaceuticals, Inc.
2 Dec 2020
Director
Sold, plan not stated
10,000
$514.33K
1.6%
ZNTL Zentalis Pharmaceuticals, Inc.
23 Nov 2020
Director
Sold, plan not stated
10,000
$465.38K
1.6%
IRD Opus Genetics, Inc.
19 Nov 2020
Director
Bought
8,865
no price
61.2%
51 decisions on file.